Market Tracker

12/06 8:53am ET

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

1.42
Delayed Data
As of Dec 05
 -0.02 / -1.39%
Today’s Change
1.32
Today|||52-Week Range
8.22
-76.91%
Year-to-Date
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Dec 04 / MotleyFool.com - Paid Partner Content
Arrowhead Pharma Shares Destroyed by Development Announcement
Nov 30 / TheStreet.com - Paid Partner Content
Here's Why Arrowhead Pharmaceuticals Inc. Is Being Obliterated Today
Nov 30 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close1.44
Today’s open1.40
Day’s range1.39 - 1.45
Volume2,399,061
Average volume (3 months)1,367,413
Market cap$86.3M
Dividend yield--
Data as of 12/05/2016

Growth & Valuation

Earnings growth (last year)-28.00%
Earnings growth (this year)+19.50%
Earnings growth (next 5 years)--
Revenue growth (last year)+118.29%
P/E ratioNM
Price/Sales864.88
Price/Book0.77

Competitors

 Today’s
change
Today’s
% change
PBMDPrima BioMed Ltd-0.05-5.53%
CASCCascadian Therapeuti...+0.05+0.91%
RKDAArcadia Biosciences ...+0.04+3.72%
AVXLAnavex Life Sciences...0.000.00%
Data as of 12/05/2016

Financials

Last reporting dateDecember 6, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$382.0K
Annual profit (last year)-$91.9M
Net profit margin-24,068.29%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christopher Richard Anzalone
Chief Operating Officer
Bruce D. Given
Corporate headquarters
Pasadena, California

Forecasts